Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ricardo Cerda-Flores"'
Autor:
Alejandra Villarreal‐Martinez, Laura Elia Martinez‐de‐Villarreal, Minerva Gomez‐Flores, Sonia Chavez‐Alvarez, Ricardo Cerda‐Flores, Jorge Ocampo‐Candiani, Consuelo Ruiz‐Herrera, Marcelo R. Rodriguez‐Rivera, Jesús Zacarías Villarreal‐Perez, José Gerardo Gonzalez‐Gonzalez, Geovana Calvo‐Anguiano
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADVREFERENCES.
Psoriasis is strongly associated with insulin resistance (IR). Lipid profile disturbances and upregulation of enzymes crucial for fatty acid oxidation have been reported in patients with psoriasis. Mitochondrial ß-oxidation is altered in patients wi
Autor:
Félix R. Cedillo-Salazar, Lizeth Martínez-Jacobo, Yadira G. Pérez-Páramo, Ricardo Cerda-Flores, Laura E. Martínez, José C. Jaime-Pérez, María G. Moreno-Treviño, Edelmiro Pérez-Rodríguez, Francisco J. Bosques-Padilla, Montserrat Cedillo-Avila, María A. Cedillo-Avila, Michelle Zamudio-Osuna
Publikováno v:
Archivos de cardiolog�a de M�xico (English ed. Internet). 89
Autor:
Félix R, Cedillo-Salazar, Lizeth, Martínez-Jacobo, Yadira X, Pérez-Páramo, Ricardo, Cerda-Flores, Laura E, Martínez, José C, Jaime-Pérez, María G, Moreno-Treviño, Edelmiro, Pérez-Rodríguez, Francisco J, Bosques-Padilla, Montserrat, Cedillo-Avila, María A, Cedillo-Avila, Michelle, Zamudio-Osuna
Publikováno v:
Archivos de cardiologia de Mexico. 89(4)
Oral antiplatelet drugs are a key to modern pharmacotherapy in cardiovascular atherothrombotic diseases. Clopidogrel (CLO) constitutes the main preventive treatment of atherothrombosis. However, a considerable inter-individual variation in CLO respon
Autor:
Raúl A, Bastarrachea, Julio C, Montero, Ictor, Saavedra-Gajardo, Ricardo, Cerda-Flores, Anselmo, Machado-Domínguez, Anthony G, Comuzzie
Publikováno v:
Revista medica de Chile. 136(1)
Current strategies to treat type 2 diabetes (DMT2) include reducing insulin resistance using glitazones, supplementing with exogenous insulin, increasing endogenous insulin production with sulfonylureas and meglitinides, reducing hepatic glucose prod